Xiao Q, Zhai L, Zhang X, Liu Y, Li J, Xie X
Animal Model Exp Med. 2024; 7(4):484-496.
PMID: 38567763
PMC: 11369037.
DOI: 10.1002/ame2.12409.
Porras D, Reid J, Tanasijevic B, Golubeva D, Boyd A, Bhatia M
Cells. 2022; 11(12).
PMID: 35741044
PMC: 9221973.
DOI: 10.3390/cells11121915.
Sampayo R, Bissell M
Adv Cancer Res. 2019; 144:315-341.
PMID: 31349902
PMC: 7314432.
DOI: 10.1016/bs.acr.2019.03.010.
Matsuoka Y, Sumide K, Sonoda Y
Stem Cell Rev Rep. 2019; 15(3):459-461.
PMID: 30982173
DOI: 10.1007/s12015-019-09884-5.
Jiang Y, Liu B, Zheng Q, Panuganti S, Chen R, Zhu J
Blood Adv. 2018; 2(14):1738-1749.
PMID: 30037800
PMC: 6058235.
DOI: 10.1182/bloodadvances.2018020107.
A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells.
Sumide K, Matsuoka Y, Kawamura H, Nakatsuka R, Fujioka T, Asano H
Nat Commun. 2018; 9(1):2202.
PMID: 29875383
PMC: 5989201.
DOI: 10.1038/s41467-018-04441-z.
Pituitary adenomas, stem cells, and cancer stem cells: what's new?.
Caffarini M, Orciani M, Trementino L, Di Primio R, Arnaldi G
J Endocrinol Invest. 2017; 41(7):745-753.
PMID: 29222642
DOI: 10.1007/s40618-017-0803-y.
Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention.
Gasch C, Ffrench B, OLeary J, Gallagher M
Mol Cancer. 2017; 16(1):43.
PMID: 28228161
PMC: 5322629.
DOI: 10.1186/s12943-017-0601-3.
Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells.
Charpentier M, Martin S
Cancers (Basel). 2013; 5(4):1545-65.
PMID: 24240660
PMC: 3875953.
DOI: 10.3390/cancers5041545.
In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells.
Amabile G, Welner R, Nombela-Arrieta C, DAlise A, Di Ruscio A, Ebralidze A
Blood. 2012; 121(8):1255-64.
PMID: 23212524
PMC: 3701251.
DOI: 10.1182/blood-2012-06-434407.
Contribution of GATA1 dysfunction to multi-step leukemogenesis.
Shimizu R, Yamamoto M
Cancer Sci. 2012; 103(12):2039-44.
PMID: 22937757
PMC: 7659349.
DOI: 10.1111/cas.12007.
Recent updates on the role of microRNAs in prostate cancer.
Hassan O, Ahmad A, Sethi S, Sarkar F
J Hematol Oncol. 2012; 5:9.
PMID: 22417299
PMC: 3313897.
DOI: 10.1186/1756-8722-5-9.
[Tumor stem cell research - basis and challenge for diagnosis and therapy].
Karlic H, Herrmann H, Schulenburg A, Grunt T, Laffer S, Mirkina I
Wien Klin Wochenschr. 2010; 122(13-14):423-36.
PMID: 20645015
DOI: 10.1007/s00508-010-1408-z.
Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor.
Harrison H, Farnie G, Howell S, Rock R, Stylianou S, Brennan K
Cancer Res. 2010; 70(2):709-18.
PMID: 20068161
PMC: 3442245.
DOI: 10.1158/0008-5472.CAN-09-1681.
MicroRNA regulation of cancer stem cells and therapeutic implications.
DeSano J, Xu L
AAPS J. 2009; 11(4):682-92.
PMID: 19842044
PMC: 2782081.
DOI: 10.1208/s12248-009-9147-7.
Isolation and therapeutic potential of human haemopoietic stem cells.
Clark A, Jorgensen H, Mountford J, Holyoake T
Cytotechnology. 2008; 41(2-3):111-31.
PMID: 19002948
PMC: 3466700.
DOI: 10.1023/A:1024822722285.
NF-kappa B-mediated adaptive resistance to ionizing radiation.
Ahmed K, Li J
Free Radic Biol Med. 2007; 44(1):1-13.
PMID: 17967430
PMC: 2266095.
DOI: 10.1016/j.freeradbiomed.2007.09.022.
[Stem cell therapy. Biology of hematopoietic stem cells].
Buske C, Glimm H, Feuring-Buske M
Internist (Berl). 2006; 47(5):459-60, 462-4.
PMID: 16575612
DOI: 10.1007/s00108-006-1602-2.
Recent translational research: stem cells as the roots of breast cancer.
Chang C
Breast Cancer Res. 2006; 8(1):103.
PMID: 16524453
PMC: 1413993.
DOI: 10.1186/bcr1385.
Mammary stem cells, self-renewal pathways, and carcinogenesis.
Liu S, Dontu G, Wicha M
Breast Cancer Res. 2005; 7(3):86-95.
PMID: 15987436
PMC: 1143566.
DOI: 10.1186/bcr1021.